Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Yangxue Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Beijing Hospital of Traditional Chinese Medicine. It is formulated based on the therapeutic principles of soothing the liver, nourishing the blood, and clearing toxins. The decoction is primarily investigated for the treatment of psoriasis, particularly in patients experiencing comorbid depressive states. Its mechanism of action is thought to involve the modulation of the Hypothalamic-Pituitary-Adrenal (HPA) axis and the melanocortin (MC) system, thereby regulating inflammatory pathways that contribute to both skin lesions and psychological distress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shugan Yangxue Jiedu Decoction.